SERUM MAGNESIUM LEVELS AMONG TYPE 2 DIABETIC PATIENTS AND PREDIABETIC SUBJECTS IN DUHOK CITY/ IRAQ

  • AZAD BASHEER SAADI Assistant lecturer in biochemistry, College of Medicine, University of Duhok, Kurdistan Region of Iraq.
  • SHERWAN FERMAN SALIH Assistant professor in clinical biochemistry, College of Medicine, University of Duhok, Kurdistan Region of Iraq.
  • AZZAM A. MOSA Assistant professor in clinical biochemistry, College of Science, University of Duhok, Kurdistan Region of Iraq.
Keywords: Hypomagnesemia, Prediabetes, Type 2, Diabetes Mellitus

Abstract

https://doi.org/10.31386/dmj.2022.16.1.1

Background: Type 2 diabetes mellitus and prediabetes are reported to be associated with
abnormalities in the metabolism of magnesium. Magnesium deficiency by itself may be a
contributing factor to the progression of Type 2 diabetes mellitus and its complications.
Methods: a cross-sectional study was carried out at the Diabetic unit in Azadi teaching
hospital. A total of 248 subjects were included in the study constituting 99 patients with
diabetes mellitus, 50 subjects with Prediabetes Mellitus and 99 as a control group that were
apparently healthy subjects.
Results: The present study has found a significant decrease in serum magnesium levels in
Type 2 diabetic patients and prediabetic subjects as compared to controls (1.88±0.23,
1.93±0.20, 2.00±0.17 mg/dl respectively, P=0.003). The rate of hypomagnesaemia was high
among diabetes patients and prediabetes subjects (23.2%, 10.0%, and 3.0%, respectively).
The highest frequency of hypomagnesaemia was found in those diabetes patients with poor
glycemic control, old age, increased fasting serum glucose, and who are also overweight and
obese.
Conclusion: Type 2 diabetes mellitus patients and Prediabetes subjects have a higher rate of
hypomagnesaemia and lower mean Mg level compared with healthy control subjects.

Downloads

Download data is not yet available.

References

Barbagallo M, Dominguez LJ.
Magnesium and type 2 diabetes World
J Diab. 2015;6(10):1152-7.
2. Anastasia P., Andrey V., Paolo P. The
Diabetes Mellitus–Atherosclerosis
Connection:The Role of Lipid and
Glucose Metabolism and Chronic
Inflammation. International journal of
molecular sciences. 2020; 21,1821-
1835.
3. American Diabetes Association.
Classification and Diagnosis of
Diabetes: Standards of Medical.
Diabetes Care. 2018; 41(1): 513-527.
4. Cantley J., Ashcroft F. insulin
secretion and type 2 diabetes. BioMed
Central. 2015; 1-7
5. Babey. S, Wolstein J., Diamant A.,
Goldstein H. Prediabetes in
California: Nearly Half of California
Adults on Path to Diabetes. Health
Policy Brief. 2016; 1-7.
6. Panesar K. Prediabetes management.
Diabetes. 2013; 38(10): 11-17.
7. Jitendra K., Wadhwani J., Manuj S.,
Dubey T. Prevalence of impaired
glucose tolerance in different grades
of obesity. International Journal of
Advances in Medicine. 2019; (6)5: 1-
4.
8. Bohn T. Magnesium Absorption in
Humans. Dissertation. University
Frankfurt, Germany. 2003.
9. Wei J., Zeng C., Li X., Gong Q., Lei
G., Yang T. Association among
dietary magnesium, serum
magnesium, and diabetes: a cross
sectional study in middle-aged and
older adults. Journal of Health,
Population and Nutrition. 2016; 2-6.
10. Meludu S., Adeniyi F. Effect of
magnesium supplementation on
plasma glucose in patients with
diabetes mellitus. Afr. J. Biomed. Res.
2001; 4: 111 – 113.
11. El-said N., Sadik N., Mohammed N.
Magnesium in type 2 diabetes mellitus
and its correlation with glycemic
control. J Res Med Sci. 2015;
3(8):1958-1963.
11
Duhok Medical Journal Volume 16, Issue 1, 2022
12. Arundhati D., Dipti S., Uma K.
Hypomagnesemia in type 2 diabetes
mellitus. Indian Journal of
Endocrinology and Metabolism. 2016;
(16)6: 1000-1003.
13. American Diabetes Association.
Standards of Medical Care in
Diabetes. Diabetes Care. 2017; 40(1):
1-135.
14. Sumathi K., Chandrika A. Role of
magnesium in pre diabetes. Scholars
Academic Journal of Pharmacy. 2015;
5(1): 12-13.
15. Kieboom B., Ligthart S., Dehghan A.,
Kurstjens S., Baaij J., Franco O. et al.
Serum magnesium and the risk of
prediabetes: a population-based cohort
study. Diabetologia. 2017; 60:843–
853.
16. James O. Subclinical magnesium
deficiency: a principal driver of
cardiovascular disease and a public
health crisis. DiNicolantonio JJ. 2018;
1-16.
17. Parlapally R., Kumari K., Jyothi S.
Serum magnesium levels in type 2
diabetes mellitus. International Journal
of Scientific Study. 2016; 4(5): 176-
179.
18. Anjum A, Yousaf M, Zuber M,
Ahmad HB, Zahoor AF. Comparative
study on calcium, magnesium and
cobalt in diabetic and non-diabetic
patients (males) in Punjab, Pakistan.
AJB 11. 2012; 7258-7262.
19. Kurstjens S., Baaij J., BourasH.,
Bindels R, Tack C., Hoenderop V.
Determinants of hypomagnesemia in
patients with type 2 diabetes mellitus.
European Journal of Endocrinology.
2017; 176: 11–19.
20. Kauser M., Afreen A., Prabhakar K,
Kumar V., Javarappa D. Study of
Serum Magnesium in Type 2 Diabetes
Mellitus and its Correlation with the
Modality of Treatment. Global Journal
of Medical Research. 2014; 14(4): 32-
37.
21. Papanas N., Maltezos E. Metformin in
the treatment of type 2 diabetes.
Clinical Medicine. 2009; 1367–1381.
22. Barbagallo M., Belvedere M.,
Dominguez L. Magnesium
homeostasis and aging. International
Magnesium Symposium. 2009; 22(4):
235-246.
23. Mamatha B., Shankarprasad D.,
Manjula R. A comparative study of
serum magnesium in type 2 diabetes
mellitus patients and non diabetics and
its correlation with glycemic status.
International Journal of Bioassays.
2014; 3 (10): 3395-3398.
24. Farooq M., Abbasi B., Ali A., Islam
N. Effect of hypomagnesemia on
control of diabetes and lipid
abnormalities. Medical Chaneel. 2017;
23(1): 5-11.
25. Wahid A., Verma G., Meena C.,
Pathan A. Study of serum magnesium
level in patients with type 2 diabetes
mellitus and it’s correlation with
glycosylated hemoglobin and diabetic
complications. International Journal of
Advances in Medicine. 2017;
4(2):311-316.
26. Chen S., Jin X., Liu J., Sun T., Xie
M., Bao W., Yu X. Association of
Plasma Magnesium with Prediabetes
and Type 2 Diabetes Mellitus in
Adults. scientific reports. 2017; 7: 1-8.
12
SERUM MAGNESIUM LEVELS AMONG TYPE 2 DIABETIC
27. Dahl A. Body mass index, cognitive
ability and dementia. dissertation.
Jonkoping University. 2009.
28. Babikr W., Shalayel M., Abdelraheem
A., Elhussein A. Impact of Body Mass
Index on Hypomagnesemia and
Hypocalcemia in Type 2 Diabetic
Patients. Biomedical & Pharmacology
Journal. 2016; 9(3): 933-940.
29. Muhammad R. Hypomagnesemia in
Type 2 Diabetes Mellitus. Pak Armed
Forces Med J. 2016; 66(6): 845-850.
30. Mane M., Chaudhari G., Reddy E.
Hypomagnesaemia in Diabetic
patients and Biochemical action on the
cardiovascular system. Int J Biol Med
Res. 2012; 3(1): 1273-1276.
31. Shaikh M., Devrajani B., Soomro A.,
Shah S., Devrajani T., DasT.
Hypomagnesemia in Patients with
Diabetes mellitus. World Applied
Sciences Journal. 2011; 12 (10): 1803-
1806.
32. Shardha A., Vaswani A., Faraz A.,
Alam M., Kumar P.. Frequency and
Risk Factors Associated with
Hypomagnesaemia in Hypokalemic
Type-2 Diabetic Patients. Journal of
Published
2022-05-29
How to Cite
SAADI, A., SALIH, S., & MOSA, A. (2022). SERUM MAGNESIUM LEVELS AMONG TYPE 2 DIABETIC PATIENTS AND PREDIABETIC SUBJECTS IN DUHOK CITY/ IRAQ. Duhok Medical Journal, 16(1), 1-14. Retrieved from https://dmj.uod.ac/index.php/dmj/article/view/171